Female Stress Incontinence
10
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
VESPER: Stress Urinary Incontinence STUDY
Investigation of Novel Non-CE Marked Catheter
Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications
Continence Pessary Versus Disposable Intravaginal Device Trial
Hybrid Versus Synthetic TOT for Treatment of SUI
Posture in Abdominopelvic Training in Women SUI
Electrostimulation PROTOCOL Incontinence
Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women
Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices
Feasibility of Comparing Two Surgical Treatment of Female Urodynamic Stress